Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-18-CE92-0031, ANR-09-GENO-021, ANR-10-INBS-09, ANR-18-CE92-0031, ANR-09-GENO-021)
Deutsche Forschungsgemeinschaft (KL 2544/6-1, KL 2544/7-1 and KL 2544/1-2, GE 2811/3-1, SFB1074/A3, OS287/4-1, GE 2811/3-1)
Assistance publique-Hôpitaux de Paris
U.S. Department of Health & Human Services | National Institutes of Health (DK068471 and DK105541, DK105831, DK105831, DK068471 and DK105541)
Boehringer Ingelheim Ulm University BioCenter
European Foundation for the Study of Diabetes
U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine
Centre of Excellence Metabolic Disorders Baden-Wuerttemberg
Received: 17 July 2020
Accepted: 13 August 2021
First Online: 18 October 2021
: The authors declare no competing interests.
Free to read: This content has been made available to all.